Literature DB >> 17143956

Loss of fragile histidine triad protein expression in inflammatory bowel disease.

Chun-Mei Xu1, Chuan-Hu Qiao.   

Abstract

AIM: To investigate the expression of fragile histidine triad (FHIT) protein in 64 patients with ulcerative colitis (UC) and Crohn's disease (CD), and its relation with clinicopathological data.
METHODS: Rabbit-anti-FHIT antibody was used to detect FHIT protein expression in 64 formalin-fixed, paraffin-embedded tissue specimens of inflammatory bowel disease (IBD) by citrate-microwave-streptavidin (SP)-HRP immunohistochemical method.
RESULTS: The positive FHIT protein expression was 22.79% +/- 16.16%, 42.14% +/- 16.82% in active and remittent phases of UC, 36.07% +/- 19.23% in CD, and 57.05% +/- 8.86% in normal colon mucosa. Statistically significant differences in FHIT protein expression were observed between the active and remittent phases of UC, between the active phase of UC and normal colon mucosa, as well as between the remittent phase of UC and normal colon mucosa, and between CD and normal colon mucosa.
CONCLUSION: Our results show that FHIT protein expression is completely absent or reduced in IBD, suggesting that the FHIT gene might be associated with the oncogenesis and progression of IBD, an early event from inflammatory conditions to carcinoma in IBD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17143956      PMCID: PMC4087498          DOI: 10.3748/wjg.v12.i45.7355

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  43 in total

1.  Kinase suppressor of Ras determines survival of intestinal epithelial cells exposed to tumor necrosis factor.

Authors:  F Yan; S K John; D B Polk
Journal:  Cancer Res       Date:  2001-12-15       Impact factor: 12.701

2.  The prevalence of loss of heterozygosity in chromosome 3, including FHIT, in bladder cancer, using the fluorescent multiplex polymerase chain reaction.

Authors:  T Wada; J Louhelainen; K Hemminki; J Adolfsson; H Wijkström; U Norming; E Borgström; J Hansson; G Steineck
Journal:  BJU Int       Date:  2001-06       Impact factor: 5.588

3.  Fragile histidine triad expression delays tumor development and induces apoptosis in human pancreatic cancer.

Authors:  K R Dumon; H Ishii; A Vecchione; F Trapasso; G Baldassarre; F Chakrani; T Druck; E F Rosato; N N Williams; R Baffa; M J During; K Huebner; C M Croce
Journal:  Cancer Res       Date:  2001-06-15       Impact factor: 12.701

4.  Aberration of FHIT gene is associated with increased tumor proliferation and decreased apoptosis-clinical evidence in lung and head and neck carcinomas.

Authors:  K Pavelić; S Krizanac; T Cacev; M P Hadzija; S Radosević; I Crnić; S Levanat; S Kapitanović
Journal:  Mol Med       Date:  2001-07       Impact factor: 6.354

5.  Direct correlation between FRA3B expression and cigarette smoking.

Authors:  Constance K Stein; Thomas W Glover; J Lynn Palmer; Bonnie S Glisson
Journal:  Genes Chromosomes Cancer       Date:  2002-07       Impact factor: 5.006

Review 6.  Common chromosomal fragile sites and cancer: focus on FRA16D.

Authors:  Louise V O'Keefe; Robert I Richards
Journal:  Cancer Lett       Date:  2005-10-20       Impact factor: 8.679

7.  Microsatellite instability in inflamed and neoplastic epithelium in ulcerative colitis.

Authors:  T Ishitsuka; H Kashiwagi; F Konishi
Journal:  J Clin Pathol       Date:  2001-07       Impact factor: 3.411

8.  Distribution of Fhit protein in rat tissues and its intracellular localization.

Authors:  F Golebiowski; R Kowara; T Pawelczyk
Journal:  Mol Cell Biochem       Date:  2001-10       Impact factor: 3.396

9.  Environmental risk factors and Crohn's disease: a population-based, case-control study in Spain.

Authors:  B Sicilia; C López Miguel; F Arribas; J López Zaborras; E Sierra; F Gomollón
Journal:  Dig Liver Dis       Date:  2001-12       Impact factor: 4.088

Review 10.  Regulation of T-cell apoptosis in inflammatory bowel disease: to die or not to die, that is the mucosal question.

Authors:  M F Neurath; S Finotto; I Fuss; M Boirivant; P R Galle; W Strober
Journal:  Trends Immunol       Date:  2001-01       Impact factor: 16.687

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.